148 related articles for article (PubMed ID: 2838634)
1. Synthesis and structure-activity relationships of 2-sulfonamido-1,3,4,6,7,11b alpha-hexahydro-2H-benzo[a]quinolizines as alpha 2-adrenoceptor antagonists.
Ward TJ; White JF; Lattimer N; Rhodes KF; Sharma S; Waterfall JF
J Med Chem; 1988 Jul; 31(7):1421-6. PubMed ID: 2838634
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and alpha 2-adrenoceptor antagonist activity of some disulfonamidobenzoquinolizines.
Ward TJ; Warrellow GJ; Stirrup JA; Lattimer N; Rhodes KF
J Med Chem; 1989 Jan; 32(1):179-82. PubMed ID: 2562854
[TBL] [Abstract][Full Text] [Related]
3. Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro.
Lattimer N; McAdams RP; Rhodes KF; Sharma S; Turner SJ; Waterfall JF
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):312-8. PubMed ID: 6151116
[TBL] [Abstract][Full Text] [Related]
4. N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonist.
Huff JR; Anderson PS; Baldwin JJ; Clineschmidt BV; Guare JP; Lotti VJ; Pettibone DJ; Randall WC; Vacca JP
J Med Chem; 1985 Dec; 28(12):1756-9. PubMed ID: 2999400
[No Abstract] [Full Text] [Related]
5. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]s.
Caroon JM; Clark RD; Kluge AF; Lee CH; Strosberg AM
J Med Chem; 1983 Oct; 26(10):1426-33. PubMed ID: 6312043
[TBL] [Abstract][Full Text] [Related]
7. Berbanes: a new class of selective alpha 2-adrenoceptor antagonists.
Vizi ES; Toth I; Somogyi GT; Szabo L; Harsing LG; Szantay C
J Med Chem; 1987 Aug; 30(8):1355-9. PubMed ID: 2886664
[TBL] [Abstract][Full Text] [Related]
8. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
9. L-654,284 a new potent and selective alpha 2-adrenoceptor antagonist.
Pettibone DJ; Clineschmidt BV; Lotti VJ; Martin GE; Huff JR; Randall WC; Vacca J; Baldwin JJ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):110-6. PubMed ID: 2875395
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the selectivity of a novel series of benzoquinolizines for alpha 2-adrenoceptors in vivo.
Paciorek PM; Pierce V; Shepperson NB; Waterfall JF
Br J Pharmacol; 1984 May; 82(1):127-34. PubMed ID: 6329385
[TBL] [Abstract][Full Text] [Related]
11. Studies of alpha 2-adrenoceptor antagonist potency in vitro: comparisons in tissues from rats, rabbits, dogs and humans.
Waterfall JF; Rhodes KF; Lattimer N
Clin Sci (Lond); 1985; 68 Suppl 10():21s-24s. PubMed ID: 2857614
[TBL] [Abstract][Full Text] [Related]
12. Some pharmacological properties of Wy 27127 a more selective alpha 2:alpha 1-adrenoceptor antagonist than idazoxan in vitro.
Bill SJ; Boniface A; Haroun F; McAdams RP; Lattimer N; Rhodes KF
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):418-22. PubMed ID: 2881217
[TBL] [Abstract][Full Text] [Related]
13. (Imidazolinyl-2)-2-benzodioxane 1-4 (idazoxan) and its stereoisomers, new alpha 2-antagonists.
Dabiré H; Mouille P; Schmitt H
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S127-9. PubMed ID: 2414573
[TBL] [Abstract][Full Text] [Related]
14. synthesis and antihypertensive activity of 2-sulfonamido- and 2-sulfamido-1,3,4,6,7,11b alpha-hexahydro-2H-benzo[a]quinolizines.
Archibald JL; Beardsley DR; Ward TJ; Waterfall JF; White JF
J Med Chem; 1983 Mar; 26(3):416-20. PubMed ID: 6827559
[No Abstract] [Full Text] [Related]
15. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
Gadie B; Lane AC; McCarthy PS; Tulloch IF; Walter DS
Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
[TBL] [Abstract][Full Text] [Related]
16. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
[TBL] [Abstract][Full Text] [Related]
17. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
Eltze M; Boer R
Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens.
Drew GM
Eur J Pharmacol; 1977 Mar; 42(2):123-30. PubMed ID: 14838
[TBL] [Abstract][Full Text] [Related]
19. Alpha-adrenoceptor blocking properties of vesamicol.
Wannan G; Prior C; Marshall IG
Eur J Pharmacol; 1991 Aug; 201(1):29-34. PubMed ID: 1686588
[TBL] [Abstract][Full Text] [Related]
20. The effects of (+/-)-idazoxan and its stereoisomers on mouse vas deferens motility in vitro. A comparison with yohimbine.
Carratù MR; Navarra P; De Serio A; Serio M; Preziosi P; Mitolo-Chieppa D
Fundam Clin Pharmacol; 1992; 6(7):301-7. PubMed ID: 1362711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
